| Literature DB >> 27646845 |
Andreas G Franke1, Sophie Lehmberg2, Michael Soyka2,3.
Abstract
BACKGROUND: Pharmacological neuroenhancement (PN) is a topic of increasing importance. Its prevalence rates range from 1 % to more than 20 %. Students are a group that shows exceptionally high prevalence rates. However, little is known about teachers' knowledge, management, attitudes and ethical judgements regarding PN.Entities:
Keywords: Misuse; Neuroenhancement; Public health concern; School; Teachers
Mesh:
Substances:
Year: 2016 PMID: 27646845 PMCID: PMC5029003 DOI: 10.1186/s13011-016-0077-y
Source DB: PubMed Journal: Subst Abuse Treat Prev Policy ISSN: 1747-597X
Basic characteristics of the survey participants
| Sex | Male: 26.3 % ( |
| Female: 63.9 % ( | |
| Not specified: 9.8 % ( | |
| Age | 20–29 years: 11.4 % ( |
| 30–39 years: 12.2 % ( | |
| 40–49 years: 24.3 % ( | |
| 50–59 years: 43.1 % ( | |
| 60 years and more: 0.8 % ( | |
| Not specified: 8.2 % ( | |
| Children living in the same household | Yes: 34.9 % ( |
| No: 53.3 % ( | |
| Not specified: 11.7 % ( | |
| Schools | Public and private elementary schools: |
| Public and private grammar schools: | |
| Vocational schools: | |
| Comprehensive schools with secondary school: | |
| Not specified: | |
| Years worked as a teacher | 1–9 years: 17.6 % ( |
| 10–19 years: 11.4 % ( | |
| 20–29 years: 29 % ( | |
| 30–39 years: 25.9 % ( | |
| 40 years and more: 0.4 % ( | |
| Not specified: 15.7 % ( |
Knowledge of teachers about substances used for PN in general and among students
| PN substance | PN substance use in general ( | PN substance use among students ( |
|---|---|---|
| Ginkgo biloba | 15.2 % | 7.1 % |
| Energy drinks | 91.9 % | 87.6 % |
| Caffeine tablets | 68 % | 46.7 % |
| MPH | 51.8 % | 43.2 % |
| AMPH | 25.9 % | 13.6 % |
| Atomoxetin | 4.6 % | 4.1 % |
| Modafinil | 2.5 % | 1.8 % |
| Antidementia drugs | 10.2 % | 3 % |
| Illicit AMPH | 48.7 % | 27.8 % |
| Ecstasy/ MDMA | 54.3 % | 32.5 % |
| Cocaine | 39.6 % | 21.3 % |
| Ephedrin | 17.8 % | 9.5 % |
| Cannabis | 47.7 % | 32 % |
77.3 % (n = 197 of n = 255) of the surveyed teachers answered “in general”; 66.3 % (n = 169 of n = 255) answered “among students”
AMPH amphetamines, MPH Methylphenidate, PN pharmacological neuroenhancement
Pro-cognitive effectiveness of potential PN substances
| PN substance | Pro-cognitive effectiveness for PN in general |
|---|---|
| No substance | 34.9 % ( |
| Ginkgo biloba | 7.1 % ( |
| Energy drinks | 29.6 % ( |
| Caffeine tablets | 42 % ( |
| MPH | 25.4 % ( |
| AMPH | 7.1 % ( |
| Atomoxetin | 1.2 % ( |
| Modafinil | 0 % ( |
| Antidementia drugs | 1.2 % ( |
| Illicit AMPH | 11.2 % ( |
| Ecstasy/ MDMA | 11.8 % ( |
| Cocaine | 11.2 % ( |
| Ephedrin | 4.7 % ( |
| Cannabis | 3 % ( |
66.3 % (n = 169) answered that question
AMPH amphetamines, MPH Methylphenidate, PN pharmacological neuroenhancement
Achieving better grades by the use of PN substances
| Better grades by the use of PN substances | Yes | No |
|---|---|---|
| Over the counter substances | 33.3 % ( | 81.8 % ( |
| Prescription drugs | 94.2 % ( | 56.1 % ( |
| Illicit drugs | 13 % ( | 90 % ( |
27.1 % (n = 69) answered that question with yes. 51.8 % (n = 132) answered that question with no
PN pharmacological neuroenhancement
PN substances use leading to addiction
| No substance | 1.2 % ( |
| Ginkgo biloba | 4.8 % ( |
| Energy drinks | 19.6 % ( |
| Caffeine tablets | 33.3 % ( |
| MPH | 51.8 % ( |
| AMPH | 42.9 % ( |
| Atomoxetin | 32.1 % ( |
| Modafinil | 30.4 % ( |
| Antidementia drugs | 33.3 % ( |
| Illicit AMPH | 86.9 % ( |
| Ecstasy/ MDMA | 88.7 % ( |
| Cocaine | 95.8 % ( |
| Ephedrin | 74.4 % ( |
| Cannabis | 82.7 % ( |
65.9 % (n = 168) answered that question
AMPH amphetamines, MPH Methylphenidate, PN pharmacological neuroenhancement
Anticipated distribution of PN substances
| PN substance | Very wide spread | Fairly spread | Scarcely spread |
|---|---|---|---|
| Ginkgo biloba | 9 % ( | 16.1 % ( | 8.2 % ( |
| Energy drinks | 0.8 % ( | 5.9 % ( | 25.5 % ( |
| Caffeine tablets | 2 % ( | 12.9 % ( | 18 % ( |
| MPH | 2 % ( | 7.5 % ( | 6.7 % ( |
| AMPH | 0.4 % ( | 2.7 % ( | 12.5 % ( |
| Atomoxetin | 1.2 % ( | 7.1 % ( | 7.1 % ( |
| Modafinil | 0 % ( | 2 % ( | 12.9 % ( |
| Antidementia drugs | 0 % ( | 6.7 % ( | 8.6 % ( |
| Illicit AMPH | 0 % ( | 0 % ( | 13.3 % ( |
65.5 % (n = 167) answered that question
AMPH amphetamines, MPH Methylphenidate, PN pharmacological neuroenhancement
Emphasis of lessons when talking about PN
| Effects | 81.6 % ( |
| Side effects | 76.3 % ( |
| Risk of addiction | 81.6 % ( |
| Warning of intake | 68.4 % ( |
| Epidemiology | 2,6 % ( |
| Information about PN | 63.2 % ( |
| Information source | 10.5 % ( |
| Helpline | 47.4 % ( |
14.9 % (n = 38) answered that question
PN pharmacological neuroenhancement